FUTURE-LOOKING

COMPANY IN AN

EVER-CHANGING

INDUSTRY

CSE: LUV

Specialize in

GENERAL WELLBEING &

SEXUAL WELLNESS

Love Pharma Holds:

Exclusive licenses to produce market package sell and  distribute patent-protected pharmaceutical

CSE:LUV

“NEW AGE”  Pharmaceuticals

CSE:LUV

CSE:LUV

PSYCHEDELICS

NUTRACEUTICALS

SEXUAL WELLNESS

CSE:LUV

🟧 Investing in proven products       that have historic revenue 🟧 Significant short and mid-       term growth catalysts. 🟧 Retail ready products for        direct, affiliate, referral &        licensing. 🟧 6 exclusively licensed        technologies 🟧 Experienced team in        Pharma & Nutraceuticals

INITIAL PRODUCT LAUNCH

Proven products and nutraceuticals to aid in mental and sexual health and wellness. 

Bloom

CBD AROUSE RX GEL WITH CBD AND/OR THC

A topical gel infused with CBD and/or THC that increases blood flow and sensitivity.

AURALIEF

CBD ORAL STRIPS

A discreet cannabis-infused oral strip that speeds-up and  enhances the desired effects of CBD.

CSE:LUV

Clinical Validation

Bloom

Auralief

(FSD)

LOVE Pharma supports all of its products with as much clinical data and research possible.

Supported by a recent human trial that demonstrated a greater than 30% increase in efficacy and speed to performance of THC and CBD.

Clinically proven to increase the number, intensity and speed of orgasm for women. 

Love Pharma's FSD supplement is supported by a clinical trial demonstrating an overall reported increase in desire, satisfaction and orgasm within women.

CSE:LUV

September 2022

Previous sales recorded from white-labeled products

$150 million    Arousal Gel Patented    Technology • $50 million    Male Enhancement Gel • $7.5 million    To Conceive 

CSE:LUV

is focused on maximizing global distribution channels to include Retail brick and mortar, online shops and referral markets.

Direct-To-Consumer

LOVE Pharma will grow market shares utilizing  its patent-protected product portfolio.

CSE:LUV

Market Comparable

Strong public companies that are leading in their respective markets

Canopy Growth Market Cap: $9 Billion Share Price: $22.96 CAD Trading Symbol: TSE:WEE

MindMed Market Cap: $1.28 billion Share Price: $2.92 USD Trading Symbol: MNMD

Ro Market Cap: $308 billion Share Price: 394.80 CHF Trading Symbol: SWX: RO

CSE:LUV

BREAKING

NEWS

CSE:LUV

CSE: LUV CHART

CSE:LUV

Previous Success

Stadnyk and Partners Venture Capital previous public company endeavors. 

CSE:LUV

Supreme

From founding group of Supreme, which was acquired by canopy for $435M in 2021

Eupraxia

Market Cap: $32 million CAD Share Price: $1.50 CAD Trading Symbol: TSX: EPRX

STRATEGIC INVESTMENT IN STARTON THERAPEUTICS

Completed in Sept 2022, a Global Biotech Leader, led by former President of of Global Primary Care and President of Europe at PFIZER

CSE:LUV

TIME LINE

Auralief CannaStrip™ Sale Ready

Bloom  Arousal Gel Sale ready

Psilocybin Infused Oral Strips

Male  Enhancement Cream

To Conceive Gel

CSE:LUV

(pending  regulatory  approval)

Anticipated Milestones

CSE:LUV

In the upcoming 12 Months

• Begin Sales of Auralief & Bloom • Launch and commence sales   of other exclusively licensed   products throughout 2022   and 2023 • Commence research initiative   with researchers at Johns    Hopkins University in Q4 2022 • Complete development of    patented psilocybin oral strip • Complete US markets listing. • Continue looking for M&A    opportunities in the pharma   and biotech space

CSE:LUV

There is much more to this story. Swipe Up